This inventor holds 1 USPTO granted patent. Top assignee: John Wyeth Brother, Limited. Active years: 1976.
Company Filing History:
Years Active: 1976
Title: The Innovative Contributions of John Arnott Boyle
Introduction: John Arnott Boyle is a notable inventor based in Maidenhead, England, recognized for his innovative work in the pharmaceutical field. His research has led to the development of a significant patent that showcases his contributions to medical science.
Latest Patents: Boyle holds a patent for (4-Quinolylamino)benzamides, specifically the compounds 3-(7-Halo-4-quinolyl)-N-[di(lower alkyl)amino(lower alkyl)]-N-(lower alkyl)benzamides and 4-(7-halo-4-quinolyl)-N-[di(lower alkyl)amino(lower alkyl)]-N-(lower alkyl)benzamides. These compounds are noted for their interesting anti-inflammatory, anti-malarial, and anti-hypertensive activities, providing exciting opportunities for therapeutic applications.
Career Highlights: John Arnott Boyle is associated with John Wyeth & Brother Limited, a company renowned for its significant advancements in pharmaceuticals. His work at Wyeth has been critical in advancing innovative solutions in treating various medical conditions.
Collaborations: Throughout his career, Boyle has collaborated with notable colleagues, including John Leheup Archibald and John Christopher Saunders. Their collective expertise has contributed to the successful development of groundbreaking inventions in their field.
Conclusion: John Arnott Boyle's contributions to innovation, particularly through his patent work, have had a substantial impact on pharmaceutical developments. His ongoing efforts in research and collaboration with his peers continue to inspire advancements in medical therapies, marking him as a prominent figure in the realm of invention.